Please login to the form below

Not currently logged in
Email:
Password:

Kite Pharma appoints head of regulatory affairs

Rizwana Sproule joins from Amgen
Kite Pharma Rizwana Sproule

Kite Pharma has appointed former Amgen executive director Dr Rizwana Sproule as head VP, regulatory affairs.

Dr Sproule spent 14 year at Amgen, most recently serving as executive director, therapeutic area head for oncology global regulatory affairs.

In this role, she oversaw Amgen's oncology products having previously held the role of global regulatory leader for the development of Amgen's Vectibix (panitumumab), which is approved to treat colorectal cancer.

Her experience prior to joining Amgen includes a regulatory affairs consultant role at the clinical research organisation (CRO) Kendle, as well as roles at SmithKline Beecham and Syntex.

Kite's chairman Dr Arie Belldegrun said: "Rizwana offers an impressive track record in guiding the regulatory process for well-recognised best-in-class therapies, and her expertise in working with international agencies – FDA, EMA/CHMP, Health Canada, and PMDA – at multiple levels will be critical to Kite's further advancement and planning.”

Dr Sproule is the latest in a string of senior appointments at Kite as the company prepares for the advance of its research projects involving cancer immunotherapies.

Other recent additions include chief financial officer Cynthia Butitta; Dr Keith Nolop as chief medical officer; and several cancer experts to the company's scientific advisory board.

22nd January 2014

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics